Activin RIIA/ACVR2A, His, Human/Cynomolgus
Activin RIIA/ACVR2A, His, Human/Cynomolgus

Immobilized Activin RIIA/ACVR2A, His, Human/Cynomolgus, His Tag at 1 μg /ml (100 μl/well) on the plate. Dose response curve for Biotinylated Human/Mouse/Rat GDF-8, Avi Tag with the EC50 of 11.5ng/ml determined by ELISA.

Activin RIIA/ACVR2A, His, Human/Cynomolgus

Immobilized Human Activin A, No Tag at 5 μg /ml (100 μl/well) on the plate. Dose response curve for Activin RIIA/ACVR2A, His, Human/Cynomolgus, His Tag with the EC50 of 0.19 μg /ml determined by ELISA.

Activin RIIA/ACVR2A, His, Human/Cynomolgus

The purity of Activin RIIA/ACVR2A, His, Human/Cynomolgus is greater than 95% as determined by SEC-HPLC.

Activin RIIA/ACVR2A, His, Human/Cynomolgus

Activin RIIA/ACVR2A, His, Human/Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Activin RIIA/ACVR2A, His, Human/Cynomolgus

Human/Mouse/Rat GDF-8, No Tag immobilized on CM5 Chip can bind Activin RIIA/ACVR2A, His, Human/Cynomolgus, His Tag with an affinity constant of 0.87 μM as determined in SPR assay (Biacore T200).

Activin RIIA/ACVR2A, His, Human/Cynomolgus

Activin A receptor type 2A (ACVR2A) is a membrane receptor in the transforming growth factor- beta (TGF-β signaling pathway, which is involved in the regulation of cell proliferation, migration, and apoptosis. Loss of ACVR2A has an important role in cancer progression and distant metastasis and may serve as a prognostic marker in patients with colon cancer.
Z04988
¥35,443.00

Ask us a question
Product Introduction
Species Human/Cynomolgus
Protein Construction
Activin RIIA/ACVR2A (Ala20-Pro135)
Accession # P27037-1 (Human) / G7PKJ4 (Cynomolgus)
His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 14.50 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 30-45 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • Activin RIIA/ACVR2A, His, Human/Cynomolgus
  • Activin RIIA/ACVR2A, His, Human/Cynomolgus

    Immobilized Activin RIIA/ACVR2A, His, Human/Cynomolgus, His Tag at 1 μg /ml (100 μl/well) on the plate. Dose response curve for Biotinylated Human/Mouse/Rat GDF-8, Avi Tag with the EC50 of 11.5ng/ml determined by ELISA.

  • Activin RIIA/ACVR2A, His, Human/Cynomolgus
  • Activin RIIA/ACVR2A, His, Human/Cynomolgus

    Immobilized Human Activin A, No Tag at 5 μg /ml (100 μl/well) on the plate. Dose response curve for Activin RIIA/ACVR2A, His, Human/Cynomolgus, His Tag with the EC50 of 0.19 μg /ml determined by ELISA.

  • Activin RIIA/ACVR2A, His, Human/Cynomolgus
  • Activin RIIA/ACVR2A, His, Human/Cynomolgus

    The purity of Activin RIIA/ACVR2A, His, Human/Cynomolgus is greater than 95% as determined by SEC-HPLC.

  • Activin RIIA/ACVR2A, His, Human/Cynomolgus
  • Activin RIIA/ACVR2A, His, Human/Cynomolgus

    Activin RIIA/ACVR2A, His, Human/Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

  • Activin RIIA/ACVR2A, His, Human/Cynomolgus
  • Activin RIIA/ACVR2A, His, Human/Cynomolgus

    Human/Mouse/Rat GDF-8, No Tag immobilized on CM5 Chip can bind Activin RIIA/ACVR2A, His, Human/Cynomolgus, His Tag with an affinity constant of 0.87 μM as determined in SPR assay (Biacore T200).


Background
Target Background Activin A receptor type 2A (ACVR2A) is a membrane receptor in the transforming growth factor- beta (TGF-β signaling pathway, which is involved in the regulation of cell proliferation, migration, and apoptosis. Loss of ACVR2A has an important role in cancer progression and distant metastasis and may serve as a prognostic marker in patients with colon cancer.
Synonyms ACTR-IIA; ACTRIIA; ACVR2A; ACVR2; ACTRII

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.